The primary antimitotic mechanism of action of the synthetic halichondrin E7389 is suppression of microtubule growth

Overview of attention for article published in Molecular Cancer Therapeutics, July 2005

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (84th percentile)
Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

policy: 1 policy source
patent: 4 patents

wikipedia: 5 Wikipedia pages

Citations

dimensions_citation: 425 Dimensions

Readers on

mendeley: 173 Mendeley

Summary Policy documents Patents Wikipedia Dimensions citations

So far, Altmetric has seen 4 patents that reference this research output.

Pharmaceutical composition for treating tumor

Grant US-11083705-B2

United States of America

Liposome composition

Grant US-11071713-B2

United States of America

Combination of a PD-1 antagonist and eribulin for treating cancer

Grant US-10945990-B2

United States of America

Method of manufacture of liposome composition

Grant US-9968583-B2

United States of America

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.